Bacil Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	583	685	610	86	32	34
Market Cap Growth	130.90%	12.33%	607.73%	166.97%	-4.36%	83.65%
Enterprise Value	578	669	610	83	28	33
Last Close Price	40.65	47.73	42.49	14.63	5.48	5.73
PE Ratio	36.62	44.04	150.92	-	-	-
PB Ratio	2.35	2.76	2.40	7.10	2.94	2.76
P/TBV Ratio	2.35	2.76	2.40	7.10	2.94	2.76
P/FCF Ratio	-	96.27	152.16	-	-	-
P/OCF Ratio	81.99	96.27	152.16	-	-	-
EV/FCF Ratio	-	94.03	152.28	-	-	-
Debt / Equity Ratio	-	-	0.01	0.08	0.02	0.03
Debt / FCF Ratio	-	-	0.41	-	-	-
Net Debt / Equity Ratio	-0.02	-0.02	-0.11	0.05	-0.18	-0.22
Net Debt / EBITDA Ratio	2.33	2.33	10.67	-0.30	1.12	1.76
Net Debt / FCF Ratio	-0.80	-0.80	-6.72	-19.64	1.35	0.07
Quick Ratio	0.68	0.68	16.92	0.37	7.87	6.49
Current Ratio	0.68	0.68	17.21	0.46	8.19	6.69
Return on Equity (ROE)	6.19%	6.19%	3.03%	-5.11%	-8.77%	-295.12%
Return on Assets (ROA)	-0.58%	-0.58%	-1.18%	-9.62%	-9.37%	-3.70%
Return on Invested Capital (ROIC)	-1.00%	-1.04%	-2.09%	-17.40%	-19.41%	-13.92%
Return on Capital Employed (ROCE)	-1.00%	-1.00%	-1.00%	-15.60%	-16.30%	-13.00%
Earnings Yield	2.67%	2.27%	0.66%	-0.69%	-3.16%	-114.37%
FCF Yield	-	1.04%	0.66%	-0.03%	-4.57%	-118.79%
Buyback Yield / Dilution	-121.94%	-121.94%	-6.92%	1.47%	-1.71%	-0.99%